JORGE BENITO
CANNATA ANDIA
Investigador hasta 2022
Hospital Universitario de Salamanca
Salamanca, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de Salamanca (9)
2022
-
Executive summary clinical practice guideline of postmenopausal, glucocorticoid-induced, and male osteoporosis (2022 update)
Revista de Osteoporosis y Metabolismo Mineral, Vol. 14, Núm. 1, pp. 5-12
2018
-
Risk of hospitalization associated with body mass index and weight changes among prevalent haemodialysis patients
Nefrologia, Vol. 38, Núm. 5, pp. 520-527
2016
-
A comprehensive fracture prevention strategy in older adults: The European union geriatric medicine society (EUGMS) statement
European Geriatric Medicine, Vol. 7, Núm. 6, pp. 519-525
-
Direct inhibition of osteoblastic Wnt pathway by fibroblast growth factor 23 contributes to bone loss in chronic kidney disease
Kidney International, Vol. 90, Núm. 1, pp. 77-89
2015
-
Plasma cardiotrophin-1 as a marker of hypertension and diabetes-induced target organ damage and cardiovascular risk
Medicine (United States), Vol. 94, Núm. 30
2013
-
Influence of body mass index on the association of weight changes with mortality in hemodialysis patients
Clinical Journal of the American Society of Nephrology, Vol. 8, Núm. 10, pp. 1725-1733
2011
-
Necrotic concentrations of cisplatin activate the apoptotic machinery but inhibit effector caspases and interfere with the execution of apoptosis
Toxicological Sciences, Vol. 122, Núm. 1, pp. 73-85
2010
-
Differential effects of 17β-estradiol and raloxifene on bone and lipid metabolism in rats with chronic kidney disease and estrogen insufficiency
Menopause, Vol. 17, Núm. 4, pp. 766-771
-
New therapies: Calcimimetics, phosphate binders and vitamin D receptor activators
Pediatric Nephrology